Images List Premium Download Classic

C Syndrome

C Syndrome-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods ...
Volant Holdings Gmbh
June 22, 2017 - N°20170173060

In one embodiment, the invention provides a method of regenerating organs and tissues in a subject suffering from one or more organ or tissue manifestations of glucose supply side associated metabolic syndrome, the method comprising: (a) confirming that the subject suffers from or is at risk for suffering from organ and/or tissue damage associated with a glucose supply side ...
NEW Methods for treating visceral fat conditions
Orexigen Therapeutics, Inc.
June 22, 2017 - N°20170172999

Disclosed are methods and compositions for treating visceral fat conditions and/or metabolic syndrome using combinations of naltrexone and bupropion.
Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta
Berg Llc
June 15, 2017 - N°20170166891

The invention provides methods of treatment of metabolic syndrome with hsp90 inhibitors, particularly hsp90β inhibitors. The invention provides methods of diagnosis and monitoring of metabolic syndrome using hsp90, particularly hsp90β, expression and activity level.
C Syndrome Patent Pack
Download + patent application PDFs
C Syndrome Patent Applications
Download + C Syndrome-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of C Syndrome-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same
Illinois Institute Of Technology
June 15, 2017 - N°20170165211

The present invention relates to a modified taurine, and a pharmaceutical composition for preventing or treating metabolic disease or a food composition, which contains the modified taurine as an active ingredient. More specifically, the modified taurine of the present invention has physical properties different from those of existing taurine, and has significant effects on the prevention and treatment of metabolic ...
Novel lactic acid bacteria and use thereof
New Bellus Enterprises Co., Ltd.
June 08, 2017 - N°20170157183

The present invention discloses novel lactic acid bacteria, which are isolated lactococcus lactis subsp. Lactis ll358 and isolated lactobacillus salivarius ls159 respectively. By administering the novel lactic acid bacteria of the present invention, renal injury, metabolic syndrome, hyperuricemia, hypocalcemia, and other disorders can be effectively ameliorated or treated.
Combination treatment of acute myeloid leukemia and myelodysplastic syndrome i
Boehringer Ingelheim International Gmbh
June 08, 2017 - N°20170157159

The present invention relates to the use of volasertib or a salt thereof or the hydrate thereof in combination with decitabine or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (aml) or myelodysplastic syndrome (mds).
C Syndrome Patent Pack
Download + patent application PDFs
C Syndrome Patent Applications
Download + C Syndrome-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of C Syndrome-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Treatment of myelodysplastic syndrome
Boehringer Ingelheim International Gmbh
June 08, 2017 - N°20170157130

The present invention relates to the use of volasertib or a pharmaceutically acceptable salt thereof or the hydrate thereof for treating myelodysplastic syndrome (mds).
Crystalline solvate forms of a pharmaceutical
Neurmedix, Inc.
June 01, 2017 - N°20170152281

The invention provides and describes solid state 17α-ethynyl-androst-5-ene-3β,7β,17β-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol include form i anhydrate and form iv and form v solvates. The invention further relates to solid ...
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial ...
New York University
June 01, 2017 - N°20170151290

The present invention relates to characterizing changes in mammalian intestinal microbiota associated with associated with high-fat and low-fat diets and with diets containing hydroxypropylmethylcellulose (hpmc) and related methods for diagnosing, preventing and treating obesity and related conditions such as metabolic syndrome and diabetes mellitus. Therapeutic methods of the invention involve the use of probiotics, and/or prebiotics, and/or narrow ...
Calcitonin mimetics for treating diseases and disorders
New York University
May 25, 2017 - N°20170143800

Calcitonin mimetic peptides having an amino acid sequence in accordance with seq id no:8 or seq id no:53, each of which may be carboxylated at its n-terminal or otherwise modified to reduce the positive charge of the first amino acid and independently of that may be amidated at its c-terminal, and in each of which the 1 and 7 position cysteine residues ...
Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1)
The General Hospital Corporation
May 18, 2017 - N°20170136095

Methods of treating obesity, metabolic syndrome, hepatic and non-hepatic steatosis, and diabetes using a pentapeptide, lvkgramide, derived from the c-terminus of glucagon-like peptide 1 (glp-1).
Methods and compositions for treating metabolic syndrome
The General Hospital Corporation
May 18, 2017 - N°20170136032

Or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, polymorph, tautomer, isotopically enriched derivative, or prodrug thereof, wherein , l, r1, r2, z, x, a and b are defined herein.
Method of treating hyperlipidemia and atherosclerosis with mir-30c
The Research Foundation For The State University Of New York
May 04, 2017 - N°20170121713

This disclosure provides a novel role for microrna (mir) regulation of lipid metabolism via the mtp pathway, leading to reductions in apob secretion and blood lipid levels. Mir regulation of the mtp pathway is shown herein to reduce hyperlipidemia and atherosclerosis in vivo. Therefore, inhibition of mtp expression and activity by mir regulation is identified as a new therapeutic target ...
C Syndrome Patent Pack
Download + patent application PDFs
C Syndrome Patent Applications
Download + C Syndrome-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of C Syndrome-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for treating obesity and/or metabolic syndrome
Mesoblast, Inc.
May 04, 2017 - N°20170119822

The present disclosure provides methods of treating or preventing obesity or causing weight loss or treating or preventing metabolic syndrome comprising administering to a subject a population of cells enriched for stro-1+ cells and/or progeny thereof and/or soluble factors derived therefrom.
Compounds influencing fatty acid uptake and metabolism and the production of inflammatory agents and methods ...
The Hershey Company
May 04, 2017 - N°20170119729

The invention provides compounds and plant extract compositions that inhibit pancreatic enzymes, such as lipases and amylases, and most particularly pancreatic lipase and phospholipase a2 (pla2), and cox-2 enzyme, and improve the inflammatory state or response conditions in animals. The compounds and plant extracts can be used in methods and administration regimens to treat animals for obesity-related conditions, diabetes and ...
Programmable electrical stimulation of the foot muscles
Stimmed Llc
April 27, 2017 - N°20170113037

System, device and method for providing neuromuscular electrical stimulation (nmes) to muscles of foot. The device includes an electrical signal generator for producing a wave pattern of variable frequency, duration, intensity, ramp time and on-off cycle. Device further includes surface electrodes for being positioned over the foot muscles or around ankles and attached to signal generator. Signal generator is programmed ...
New treatment
Verona Pharma Plc
April 27, 2017 - N°20170112839

The invention provides a compound for use in treating or preventing a disease or condition selected from cystic fibrosis, chronic obstructive pulmonary disease (copd), asthma, mild pulmonary disease, bronchitis, bronchiectasis, idiopathic bronchiectasis, allergic bronchopulmonary aspergillosis, sinusitis, rhinosinusitis, cftr-related metabolic syndrome (crms), pancreatitis, idiopathic chronic pancreatitis and sjörgren's syndrome, or for use in preventing male infertility caused by congenital ...
Novel biological detection method for dioxins in serum, and a diagnostic use therefor in metabolic ...
University-industry Cooperation Group Of Kyung Hee
April 20, 2017 - N°20170107584

The present invention relates to a novel biological detection method for dioxins in serum and a diagnostic use thereof in metabolic syndrome and related conditions. More particularly, according to the present invention, a significant correlation between dioxin content in serum and physical variables has been confirmed by measuring luciferase activity through the use of serum as a whole and cells ...
Phenyl-substituted nicotinic ligands, and methods of use thereof
Duke University
April 20, 2017 - N°20170107197

Disclosed are compounds and methods of using them to treat a disorder selected from the group consisting of addiction, pain, obesity, schizophrenia, epilepsy, mania and manic depression, anxiety, alzheimer's disease, learning deficit, cognition deficit, attention deficit, memory loss, lewy body dementia, attention deficit hyperactivity disorder (adhd), parkinson's disease, huntington's disease, tourette's syndrome, amyotrophic lateral sclerosis, inflammation, stroke, spinal cord injury, ...
Composition for preventing and treating non-alcoholic fatty liver diseases
Jbk Natural Medicine Institute
April 20, 2017 - N°20170106035

A composition includes a black chokeberry extract and at least one of a thistle extract, a black hoof mushroom extract and a mixture thereof. The composition is effective in preventing and treating non-alcoholic fatty liver disease caused by accumulation of fat in the liver due to excessive intake of nutrients or metabolic syndrome regardless of alcohol intake. The composition can ...
Activation of amp-protein activated kinase by oxaloacetate compounds
Jbk Natural Medicine Institute
April 20, 2017 - N°20170105954

The present invention relates to oxaloacetate compounds that activate amp-activated protein kinase (ampk), including the preparation of the compounds, compositions containing the compounds, preserving said compounds and the use of the compounds in the prevention or treatment of disorders such as diabetes, metabolic syndrome, obesity, cardiovascular disease, alzheimer's disease, and cancer.
Loading